Osteoporosis Disease Management Demonstration Project

This study is ongoing, but not recruiting participants.

Sponsored by:	Merck
Information provided by:	Merck
ClinicalTrials.gov Identifier:	NCT00145067

Purpose

The purpose of the study is to evaluate the impact disease management interventions in treatment compliance among post-fracture and osteoporosis patients.

Condition	Intervention
Osteoporosis	Behavioral: Disease Management Assessment

MedlinePlus related topics: Osteoporosis

U.S. FDA Resources

Study Type:	Interventional
Study Design:	Educational/Counseling/Training, Randomized, Open Label, Placebo Control, Parallel Assignment
Official Title:	Three Methods of Delivering Health Care for Secondary Prevention of Osteoporosis

Further study details as provided by Merck:

Primary Outcome Measures:

Treatment persistence

Secondary Outcome Measures:

Patient satisfaction and knowledge

Estimated Enrollment:	230
Study Start Date:	November 2003

Eligibility

Ages Eligible for Study:	60 Years and older
Genders Eligible for Study:	Female
Accepts Healthy Volunteers:	No

Criteria

Inclusion Criteria:

Members of of the Kaiser Permanente Health Plan who have fractured a bone.

Exclusion Criteria:

Individuals who are not members of the Kaiser Permanente Health Plan.

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00145067

Sponsors and Collaborators

Merck

Investigators

Study Director:

Medical Monitor

Merck

More Information

Study ID Numbers:	2005_051
Study First Received:	September 1, 2005
Last Updated:	September 7, 2005
ClinicalTrials.gov Identifier:	NCT00145067
Health Authority:	United States: Institutional Review Board

Study placed in the following topic categories:

Musculoskeletal Diseases
Neoplasm Metastasis
Osteoporosis
Bone Diseases, Metabolic
Bone Diseases

ClinicalTrials.gov processed this record on January 16, 2009